过去一年中添加的文章,按日期排序
Adaptive immunity in atherosclerosis
B Slütter, K Ley - Frontiers in Immunology, 2024 - frontiersin.org
27 天前 - … -specific deletion of CBL-B (CBL-B TKO) reduced atherosclerosis in the aortic arch
and root, but modestly increased plaque T cell infiltration and systemic T cell activation. The …
and root, but modestly increased plaque T cell infiltration and systemic T cell activation. The …
[PDF][PDF] The role of co-stimulatory molecules CD40/CD40L during the immune response after acute myocardial infarction
S Witkowski - docserv.uni-duesseldorf.de
27 天前 - … the T cell-specific genetic depletion of CD40L also showed great potential by achieving
similar effects in the acute … with some forms of CVD like acute coronary syndromes[103], …
similar effects in the acute … with some forms of CVD like acute coronary syndromes[103], …
Long‐lasting, biochemically modified mRNA, and its frameshifted recombinant spike proteins in human tissues and circulation after COVID‐19 vaccination
LG Boros, AM Kyriakopoulos, C Brogna… - Pharmacology …, 2024 - Wiley Online Library
28 天前 - … ) mRNA can elicit cellular immunity to peptide antigens … These products impact
on off-target host T cell immunity that … increase the risk of acute cardiac events 31 due to the …
on off-target host T cell immunity that … increase the risk of acute cardiac events 31 due to the …
POS0144 MULTI-MODAL IMMUNE DYNAMICS OF PRE-COVID-19 KAWASAKI DISEASE FOLLOWING INTRAVENOUS IMMUNOGLOBULIN
39 天前 - … coronary artery involvement (CAI+) compared to CAI- patients (p=0.0018, Figure 1E).
Phenotype analysis of T cell … and a comprehensive immune activation and exhaustion with …
Phenotype analysis of T cell … and a comprehensive immune activation and exhaustion with …
GPR15-dependent T cell recruitment in the acute phase of viral myocarditis is associated with improved virus elimination and outcome
D Lindner, H Brauninger, B Stoffers… - Cardiovascular …, 2024 - academic.oup.com
42 天前 - … to differences in immune cell infiltration or inflammation in the acute phase of
myocarditis; (ii) does it affect elimination of CVB3 and thus outcome; (iii) does it affect immune cell …
myocarditis; (ii) does it affect elimination of CVB3 and thus outcome; (iii) does it affect immune cell …
[HTML][HTML] Early, rapidly progressive vasculopathy in a transplanted heart: a possible complication of COVID-19
BG Pearson, DH Walker, AS Lea, W Khalife… - Cardiovascular …, 2024 - Elsevier
45 天前 - … hospital for acute renal failure and subsequently diagnosed with moderate acute T
cell-… that the COVID-19 syndrome was associated with a host of immune-related and other …
cell-… that the COVID-19 syndrome was associated with a host of immune-related and other …
[HTML][HTML] Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromes
K Pekayvaz, C Losert, V Knottenberg, C Gold… - Nature Medicine, 2024 - nature.com
50 天前 - … chronic coronary syndromes (CCS) and acute coronary … In summary, an early T
cell maturation and activation state … phenotype and shape the immune landscape in ACS. …
cell maturation and activation state … phenotype and shape the immune landscape in ACS. …
[PDF][PDF] FEATURES OF T-CELL AND HUMORAL IMMUNITY OF PATIENTS WITH ACUTE CORONARY SYNDROME, WITH AND WITHOUT COVID-19, DEPENDING …
EA Safronova, LV Ryabova, АV Zurochka… - … Infection and Immunity, 2024 - iimmun.ru
55 天前 - … The aim of the work was to assess the T-cell and humoral immune arms in patients
with acute coronary syndrome (ACS) recovered from or not exposed to Covid-19. 86 men …
with acute coronary syndrome (ACS) recovered from or not exposed to Covid-19. 86 men …
Single-Cell RNA Sequencing Reveals an Immune Landscape of CD4+ T Cells in Coronary Culprit Plaques With Acute Coronary Syndrome in Humans—Brief Report
S Takeda, T Emoto, T Yamashita… - … and Vascular Biology, 2024 - Am Heart Assoc
97 天前 - … with chronic coronary syndrome (chronic coronary syndrome … percutaneous
coronary intervention with directional coronary … T cell immunity. Circulation. 2014;130:1363–1373. …
coronary intervention with directional coronary … T cell immunity. Circulation. 2014;130:1363–1373. …
PEMBROLIZUMAB INDUCED MYOCARDITIS DISGUISED AS ACUTE CORONARY SYNDROME
RAM Kalathil, H Ahmed, A Palicherla… - Journal of the American …, 2024 - jacc.org
99 天前 - … Pembrolizumab (PEM) is an immune checkpoint inhibitor. It inhibits PD-1 receptors
thereby enhancing anti-tumor T-cell activity. It is a novel anti-cancer drug. However, it is …
thereby enhancing anti-tumor T-cell activity. It is a novel anti-cancer drug. However, it is …